24-07-2024 |
PM |
|
BSX |
Boston Scientific Corporation |
115,070 |
0.62 |
0.58 |
0.53 |
Boston Scientific beats top-line and bottom-line estimates; initiates Q3 and raises FY24 outlook [7/24/2024 6:36 AM] |
77.53 |
-1.06 (-1.34%) |
76.64 |
-1.95 (-2.48%) |
48.35 - 79.43 |
11,146,101 |
6,020,000 |
1,915,778 |
|
|
24-04-2024 |
PM |
|
BSX |
Boston Scientific Corporation |
99,790 |
0.56 |
0.51 |
0.47 |
Boston Scientific Non-GAAP EPS of $0.56 beats by $0.05, revenue of $3.86B beats by $180M [4/24/2024 6:32 AM] |
72.86 |
3.87 (5.61%) |
73.00 |
4.01 (5.81%) |
48.35 - 74.39 |
12,410,344 |
6,560,000 |
107,757 |
|
|
31-01-2024 |
PM |
|
BSX |
Boston Scientific |
89,554 |
0.55 |
0.51 |
0.00 |
Boston Scientific beats top-line and bottom-line estimates; initiates Q1 and FY24 outlook [1/31/2024 6:34 AM] |
63.35 |
1.93 (3.15%) |
64.10 |
2.68 (4.36%) |
45.57 - 64.49 |
11,016,496 |
7,300,000 |
129,517 |
|
|
26-10-2023 |
PM |
|
BSX |
Boston Scientific Corporation |
74,620 |
0.50 |
0.48 |
0.43 |
Boston Scientific Non-GAAP EPS of $0.50 beats by $0.02, revenue of $3.53B beats by $50M [10/26/2023 6:34 AM] |
49.80 |
-0.19 (-0.38%) |
50.75 |
0.76 (1.52%) |
40.93 - 55.38 |
10,923,194 |
9,230,000 |
44,530 |
|
|
27-07-2023 |
PM |
|
BSX |
Boston Scientific Corporation |
75,000 |
0.53 |
0.49 |
0.44 |
Boston Scientific Non-GAAP EPS of $0.53 beats by $0.04, revenue of $3.59B beats by $90M [7/27/2023 6:39 AM] |
52.66 |
0.27 (0.51%) |
53.14 |
0.74 (1.41%) |
37.74 - 54.74 |
9,689,353 |
6,460,000 |
43,176 |
|
|
26-04-2023 |
PM |
6:30 AM ET (Apr 26) |
BSX |
Boston Scientific Corporation |
73,790 |
0.47 |
0.43 |
0.39 |
Boston Scientific Non-GAAP EPS of $0.47 beats by $0.04, revenue of $3.39B beats by $230M [4/26/2023 6:33 AM] |
51.08 |
-0.03 (-0.06%) |
52.50 |
1.39 (2.72%) |
34.98 - 53.21 |
16,899,949 |
11,170,000 |
567,135 |
|
|
01-02-2023 |
PM |
6:30 AM ET (Feb 1) |
BSX |
Boston Scientific Corporation |
65,610 |
0.45 |
0.47 |
0.45 |
Boston Scientific Non-GAAP EPS of $0.45 misses by $0.02, revenue of $3.24B in-line [2/1/2023 6:32 AM] |
47.55 |
1.30 (2.81%) |
46.40 |
0.15 (0.32%) |
34.98 - 47.95 |
13,545,727 |
6,630,000 |
283,254 |
|
|
26-10-2022 |
PM |
6:30 AM ET (Oct 26) |
BSX |
Boston Scientific Corporation |
58,670 |
0.43 |
0.44 |
0.41 |
Boston Scientific Non-GAAP EPS of $0.43 misses by $0.01, revenue of $3.17B beats by $30M, lowers FY22 outlook [10/26/2022 6:34 AM] |
41.86 |
0.56 (1.36%) |
42.30 |
1.00 (2.42%) |
34.98 - 47.49 |
16,067,016 |
8,250,000 |
757,334 |
|
|
27-07-2022 |
PM |
6:30 AM ET (Jul 27) |
BSX |
Boston Scientific Corporation |
54,500 |
0.44 |
0.42 |
0.40 |
Boston Scientific Non-GAAP EPS of $0.44 beats by $0.02, revenue of $3.24B beats by $20M, cuts FY22 outlook [7/27/2022 6:35 AM] |
40.36 |
2.40 (6.32%) |
39.95 |
1.99 (5.24%) |
34.98 - 47.49 |
15,594,507 |
7,890,000 |
54,717 |
|
|
27-04-2022 |
PM |
6:30 AM ET (Apr 27) |
BSX |
Boston Scientific Corporation |
63,740 |
0.39 |
0.38 |
0.37 |
Boston Scientific Non-GAAP EPS of $0.39 in-line, revenue of $3.03B beats by $80M [4/27/2022 6:32 AM] |
43.05 |
0.45 (1.04%) |
43.55 |
0.95 (2.23%) |
37.96 - 47.49 |
12,314,019 |
8,510,000 |
33,753 |
|
|
02-02-2022 |
PM |
6:30 AM ET (Feb 2) |
BSX |
Boston Scientific Corporation |
60,900 |
0.45 |
0.44 |
0.23 |
Boston Scientific Non-GAAP EPS of $0.45 beats by $0.01, revenue of $3.13B beats by $20M [2/2/2022 6:32 AM] |
41.58 |
-1.92 (-4.41%) |
41.97 |
-1.53 (-3.52%) |
35.97 - 46.28 |
23,225,703 |
11,470,000 |
436,189 |
|
-
Boston Scientific Q4 2021 Earnings Preview [2/1/2022 2:10 PM]
-
Boston Scientific Non-GAAP EPS of $0.45 beats by $0.01, revenue of $3.13B beats by $20M [2/2/2022 6:32 AM]
-
Boston Scientific down 4% after issuing Q1 and FY 2022 guidance below consensus [2/2/2022 7:38 AM]
-
Ownership Capital B.V. Buys Veeva Systems Inc, DexCom Inc, CoStar Group Inc, Sells Boston ... [Feb-01-22 09:38AM]
-
LEADing Change for Employees With Disabilities [Feb-01-22 08:50AM]
-
Medical Products Stock Earnings on Feb 2: BSX, TMO & More [Feb-01-22 08:33AM]
-
BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2021 [Feb-02-22 06:30AM]
-
Boston Scientific net income drops, outlook falls short of Wall Street view [Feb-02-22 06:57AM]
-
Boston Scientific Tumbles On Lackluster Guidance Despite Fourth-Quarter Beat [Feb-02-22 09:17AM]
-
Boston Scientific (BSX) Q4 Earnings and Revenues Beat Estimates [Feb-02-22 07:45AM]
-
Earnings Beat Views, But Boston Scientific Drops On Lackluster Guidance [Feb-02-22 10:24AM]
-
Boston Scientific Falls as Revenue Outlook Disappoints [Feb-02-22 05:42AM]
-
Boston Scientific (BSX) Q4 Earnings Top Estimates, Margins Up [Feb-02-22 11:38AM]
-
Did Hedge Funds Catch A Break With Boston Scientific Corporation (BSX)? [Feb-02-22 07:31PM]
-
RBA Wealth Management, LLC Buys UnitedHealth Group Inc, Microsoft Corp, Prologis Inc, Sells ... [Feb-02-22 05:38PM]
|
27-10-2021 |
PM |
6:30 AM ET (Oct 27) |
BSX |
Boston Scientific Corporation |
63,850 |
0.41 |
0.40 |
0.37 |
Boston Scientific EPS beats by $0.01, misses on revenue [10/27/2021 6:35 AM] |
43.73 |
-0.59 (-1.33%) |
43.73 |
0.0 (0.00%) |
32.99 - 46.28 |
6,906,119 |
5,620,000 |
33,904 |
|
|
27-07-2021 |
PM |
6:30 AM ET (Jul 27) |
BSX |
Boston Scientific Corporation |
62,690 |
0.40 |
0.37 |
0.08 |
Boston Scientific EPS beats by $0.03, beats on revenue, raises FY21 outlook [7/27/2021 6:33 AM] |
45.51 |
1.54 (3.49%) |
44.50 |
0.53 (1.21%) |
32.99 - 46.03 |
13,000,808 |
5,770,000 |
8,376 |
|
|
28-04-2021 |
PM |
6:30 AM ET (Apr 28) |
BSX |
Boston Scientific Corporation |
60,050 |
0.37 |
0.30 |
0.28 |
Boston Scientific EPS beats by $0.06, beats on revenue [4/28/2021 6:32 AM] |
44.29 |
1.88 (4.43%) |
43.80 |
1.39 (3.28%) |
32.99 - 44.63 |
14,758,267 |
9,360,000 |
239,112 |
|
|
03-02-2021 |
PM |
6:30 AM ET (Feb 3) |
BSX |
Boston Scientific Corporation |
50,910 |
0.23 |
0.31 |
0.46 |
Boston Scientific EPS misses by $0.08, misses on revenue [2/3/2021 6:31 AM] |
37.49 |
-0.26 (2.32%) |
36.48 |
-0.16 (-0.44%) |
24.10 - 43.44 |
14,883,122 |
11,450,280 |
106,504 |
|
-
Boston Scientific EPS misses by $0.08, misses on revenue [2/3/2021 6:31 AM]
-
Boston Scientific Q4 2020 Earnings Preview [2/2/2021 1:01 PM]
-
Boston Scientific Q4 topline falls 7%, provides 2021 forecast [2/3/2021 8:36 AM]
-
iRhythm fade continues as competitor talks about reimbursement issues [2/3/2021 1:27 PM]
-
Boston Scientific Corp (BSX) Q4 2020 Earnings Call Transcript [Feb-03-21 01:30PM]
-
Boston Scientific (BSX) Q4 Earnings Miss, Margins Decline [Feb-03-21 10:42AM]
-
Boston Scientific Announces Results For Fourth Quarter And Full Year 2020 [Feb-03-21 06:30AM]
-
Has Boston Scientific (NYSE:BSX) Got What It Takes To Become A Multi-Bagger? [Feb-03-21 12:05AM]
-
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Boston Scientific Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 2, 2021 - BSX [Feb-02-21 01:36PM]
-
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Boston Scientific Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Feb-02-21 12:05PM]
-
CLASS ACTION UPDATE for BSX, SWI and JFU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders [Feb-02-21 12:00PM]
-
BSX Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Boston Scientific Corporation Shareholders of Class Action and Lead Plaintiff Deadline: February 3, 2021 [Feb-02-21 11:00AM]
-
Lawsuits Filed Against BSX, SWI and JFU - Jakubowitz Law Pursues Shareholders Claims [Feb-02-21 09:30AM]
-
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Boston Scientific Corporation and Encourages Investors with Losses of $100,000 to Contact the Firm [Feb-02-21 09:11AM]
-
BSX Final Deadline Today: Rosen, National Trial Counsel, Reminds Boston Scientific Corporation Investors of Important February 2 Deadline in Securities Class Action - BSX [Feb-02-21 08:41AM]
-
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BSX, SWI and OTGLY [Feb-02-21 06:30AM]
-
BOSTON SCIENTIFIC 24 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Boston Scientific Corporation - BSX [Feb-02-21 01:50AM]
|
28-10-2020 |
PM |
6:30 AM ET (Oct 28) |
BSX |
Boston Scientific Corporation |
53,180 |
0.37 |
0.25 |
0.39 |
Boston Scientific EPS beats by $0.12, beats on revenue [10/28/2020 6:31 AM] |
34.05 |
-0.30 (-5.55%) |
36.20 |
0.15 (0.42%) |
24.10 - 46.62 |
16,542,945 |
12,632,880 |
25,011 |
|
|
29-07-2020 |
PM |
6:30 AM ET (Jul 29) |
BSX |
Boston Scientific Corporation |
54,790 |
0.08 |
-0.04 |
0.39 |
Boston Scientific EPS beats by $0.10, beats on revenue [7/29/2020 6:32 AM] |
39.50 |
1.23 (3.21%) |
39.95 |
1.68 (4.39%) |
24.10 - 46.62 |
8,036,320 |
8,064,782 |
113,501 |
|
|